Neurological Aspects of COVID-19: What We Knew Then, What We Know Now, & What We Need to Prepare for in the Future
A special issue of Neurology International (ISSN 2035-8377).
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 12316
Special Issue Editors
2. Department of Medicine (Neurology) John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA
3. Graduate Faculty, Clinical & Translational Research, Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA
Interests: neurology; neuroscience; neuroimmunology; COVID-19
Special Issues, Collections and Topics in MDPI journals
2. Department of Medicine (Neurology) John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA
3. Graduate Faculty, Clinical & Translational Research, Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA
Interests: neurology; neuroscience; neuroimmunology; COVID-19
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neurological complications of Coronavirus disease 2019 (COVID-19) were first recognized during the initial outbreak in Wuhan, China. Since then, a great deal of information has been shared about the neurological aspects of COVID-19, including acute neurological manifestations such as encephalopathy, cerebrovascular diseases, neuromuscular diseases, and smell and taste disorders. Long-term persistent complications, such as the cognitive effects of COVID-19, are equally important. Other issues include management of immunosuppressive therapy and neurological side effects associated with COVID-19 treatments and vaccines. A better understanding of the neuropathogenesis, including neuronal and immune dysfunction, renin–angiotensin system dysfunction and viral invasion of the nervous system, will enhance our understanding of these clinicopathologic conditions.
We dedicate this Special Issue of “Neurological Aspects of COVID-19: What We Knew Then, What We Know Now, & What We Need to Prepare for in the Future” as a “Call for Action”, and invite the medical and scientific community to join us in raising awareness promoting early and accurate diagnosis. This will result in more favourable treatments and outcomes for the growing number of patients worlwide who are affected by COVID-19.
Prof. Dr. Kore Kai Liow
Prof. Dr. Jason Viereck
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Neurology International is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- SARS-CoV-2
- COVID-19
- neurological complications
- cerebrovascular complications
- encephalopathy
- meningoencephalitis
- rhombencephalitis
- acute disseminated encephalomyelitis (ADEM)
- acute hemorrhagic necrotizing encephalopathy
- multisystem inflammatory syndrome in children
- seizures and status epilepticus
- posterior reversible encephalopathy syndrome (PRES)
- neuromuscular disorders
- Guillain-Barré syndrome
- myositis
- focal and multifocal neuropathies Critical illness neuropathy and myopathy
- smell and taste disorders
- demyelinating disorders
- long COVID
- post-COVID syndrome
- post-acute sequelae of SARS-CoV-2 infection
- post-COVID conditions
- COVID nervous system invasion
- COVID-19 treatments
- post-acute COVID-19 syndrome
- neurological complications COVID vaccine
- risk of COVID with immune therapy in neurological patients
- cognitive dysfunction
- Brain Fog
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.